Sequencing of treatments for advanced kidney cancer remains uncertain

There are now a number of licensed drug options available for the treatment of advanced renal cell carcinoma (RCC). Many of them have data supporting their use as first- and second-line treatments. However, it is still not clear what sequence these drugs should be used in, especially as data coming out of clinical trials may […]

read more

The 100,000 Genomes Project

An ambitious project to sequence 100,000 genomes is making great progress: All 13 NHS Genomic Medicine Centres are recruiting rare disease and cancer patients to the project, and initiatives in Scotland, Northern Ireland and Wales are joining this world leading programme. There are nearly 20,000 genomes in the project’s datacentre, and the research groups are collaborating with the National […]

read more
Showing all 2 results